Literature DB >> 25060251

Acute leukemia.

Hayley Rose-Inman1, Damon Kuehl2.   

Abstract

Although great progress has been made in the understanding and treatment of acute leukemia, this disease has not been conquered. For emergency providers (EPs), the presentation of these patients to an emergency department presents a host of challenges. A patient may present with a new diagnosis of leukemia or with complications of the disease process or associated chemotherapy. It is incumbent on EPs to be familiar with the manifestations of leukemia in its various stages and maintain some suspicion for this diagnosis, given the nebulous and insidious manner in which leukemia can present.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute leukemia; Acute lymphoblastic leukemia; Acute myelogenous leukemia; Emergency providers

Mesh:

Year:  2014        PMID: 25060251     DOI: 10.1016/j.emc.2014.04.004

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  12 in total

1.  Intraparenchymal Hemorrhage: A Fatal Presentation of Undiagnosed Acute Myelogenous Leukemia.

Authors:  Rachelle Hamadi; Marc Assaad; Juda Zurndorfer; Khalil El Gharib; Raymond Kwok; Meekoo Dhar; Alfred Schwab
Journal:  Cureus       Date:  2022-06-02

2.  miR-126 promotes the growth and proliferation of leukemia stem cells by targeting DNA methyltransferase 1.

Authors:  Qian Ding; Qing Wang; Yi Ren; Hongqian Zhu; Zhujun Huang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

3.  An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells.

Authors:  Min-Wu Chao; Han-Li Huang; Wei-Chun HuangFu; Kai-Cheng Hsu; Yi-Min Liu; Yi-Wen Wu; Chao-Feng Lin; Yi-Lin Chen; Mei-Jung Lai; Hsueh-Yun Lee; Jing-Ping Liou; Che-Ming Teng; Chia-Ron Yang
Journal:  Oncotarget       Date:  2017-04-25

4.  A comparative proteomic study of plasma in Colombian childhood acute lymphoblastic leukemia.

Authors:  Sandra Isabel Calderon-Rodríguez; María Carolina Sanabria-Salas; Adriana Umaña-Perez
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

Review 5.  Aberrant Phenotypes in Acute Myeloid Leukemia and Its Relationship with Prognosis and Survival: A Systematic Review and Meta-Analysis.

Authors:  Lucio Henrique Sousa Pinheiro; Louise Dantas Trindade; Fernandes de Oliveira Costa; Nathanielly de Lima Silva; Alex Freire Sandes; Marco Antônio Prado Nunes; Cristiane Bani Correa; Carlos Arthur Cardoso Almeida; Geydson Silveira da Cruz; Divaldo Pereira de Lyra Junior; Dulce Marta Schimieguel
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-10-01

6.  The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.

Authors:  Mohammad Mohammadi; Yang Cao; Ingrid Glimelius; Matteo Bottai; Sandra Eloranta; Karin E Smedby
Journal:  BMC Cancer       Date:  2015-11-05       Impact factor: 4.430

7.  Bioinformatics and experimental studies of anti-leukemic activity from 6-gingerol demonstrate its role in p53 mediated apoptosis pathway.

Authors:  Chawalit Chatupheeraphat; Chanin Nantasenamat; Kamolchanok Deesrisak; Sittiruk Roytrakul; Usanarat Anurathapan; Dalina Tanyong
Journal:  EXCLI J       Date:  2020-05-06       Impact factor: 4.068

8.  Risk factors associated with suicide among leukemia patients: A Surveillance, Epidemiology, and End Results analysis.

Authors:  Haohui Yu; Ke Cai; Yulin Huang; Jun Lyu
Journal:  Cancer Med       Date:  2020-10-06       Impact factor: 4.452

9.  PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability.

Authors:  Ling Jin; Laigen Tong
Journal:  Immun Inflamm Dis       Date:  2021-05-06

10.  Sudden Unexpected Death Caused by Cardiac Metastasization from Histiocytic Sarcoma.

Authors:  Alessandro Feola; Paola Ciamarra; Mariavictoria De Simone; Anna Carfora; Gelsomina Mansueto; Carlo Pietro Campobasso
Journal:  Int J Environ Res Public Health       Date:  2021-12-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.